title: Effects of GABAergic modulators on food and cocaine self-administration in baboons.
abstract: Drugs that indirectly alter dopaminergic systems may alter the reinforcing effects of cocaine. The inhibitory neurotransmitter gamma-aminobutyric acid (GABA) has extensive neural connections in mesolimbic regions that appear to modulate dopamine. The current study evaluated the effects of GABA(B) receptor agonists baclofen and CGP44532, the benzodiazepine agonist alprazolam, and the GABA reuptake inhibitor tiagabine on lever responding maintained by low dose cocaine injections (0.032 mg/kg) or by food pellet (1 g) delivery in baboons. The benzodiazepine antagonist flumazenil was tested as a negative control. Cocaine or food was available under a fixed ratio (FR 10) schedule of reinforcement during daily 2-h sessions. During baseline conditions, cocaine and pellets maintained similar numbers of reinforcers per session. Baclofen, CGP44532 and tiagabine dose-dependently reduced the number of cocaine injections, where as the benzodiazepine antagonist flumazenil did not. Baclofen, CGP44532 and tiagabine also produced dose-related decreases in food-maintained behavior. In contrast, the benzodiazepine agonist alprazolam, which positively modulates GABA(A) receptors via the benzodiazepine site, produced decreases in cocaine self-injection, but not food-maintained behavior. Thus, the effects of alprazolam were specific for cocaine-maintained behavior, where as the effects of baclofen and CGP44532 were not.
authors: Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University, Behavioral Biology Research Center, 5510 Nathan Shock Dr./Suite 3000, Baltimore, MD 21224-6823, USA. eweerts@jhmi.edu
authors: Elise M
authors: EM
authors: Weerts
authors: Wolfgang
authors: W
authors: Froestl
authors: Roland R
authors: RR
authors: Griffiths
mesh_terms: D000525:Alprazolam / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001418:Baclofen / Q000008:administration & dosage / Q000494:pharmacology*; D003042:Cocaine / Q000008:administration & dosage* / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D005247:Feeding Behavior / Q000187:drug effects*; D018755:GABA Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D018757:GABA Modulators / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D008297:Male; D009557:Nipecotic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D048530:Papio anubis; D012054:Reinforcement, Psychology; D012646:Self Administration; D000078308:Tiagabine
chemical_list: D018755:GABA Agonists; D018757:GABA Modulators; D009557:Nipecotic Acids; D001418:Baclofen; D003042:Cocaine; D004298:Dopamine; D000525:Alprazolam; D000078308:Tiagabine